The European Medicines’ (EMA) human medicines committee (CHMP) has recommended seven novel medicines for approval at its July ...

TCG Labs Soleil has secured another $400 million to expand its global R&D footprint and help build out its growing portfolio ...

Semaglutide, a GLP-1R agonist developed by Denmark’s Novo Nordisk as Ozempic, initially for type 2 diabetes, and marketed ...

Chief executive Thomas Schinecker believes the price of drugs in the USA could be lowered considerably if this model were ...